Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC40689 C6 L-erythro Ceramide (d18:1/6:0)

    L-erythro Cer(d18:1/6:0), L-erythro Ceramide (d18:1/6:0), N-hexanoyl-L-erythro-Sphingosine

    A bioactive sphingolipid
  3. GC40688 C6 D-threo Ceramide (d18:1/6:0)

    N-hexanoyl-D-threo-Sphingosine, D-threo Cer(d18:1/6:0), D-threo Ceramide (d18:1/6:0)

    A bioactive sphingolipid
  4. GC40675 2-deoxy-Artemisinin

    脱氧青蒿素

    An inactive metabolite of artemisinin
  5. GC40673 Geranyl Acetate

    乙酸香叶酯

    A monoterpene with diverse biological activities
  6. GC40669 Nerol

    橙花醇

    A monoterpene
  7. GC40664 Colcemid

    秋水仙碱,Demecolcine

    Colcemid是一种细胞骨架抑制剂,可以在哺乳动物细胞或卵母细胞中诱导G2/M期的有丝分裂停滞或囊泡破裂(GVBD)期的减数分裂停滞。
  8. GC40650 CAY10706 A TrxR inhibitor
  9. GC40614 Anhydroepiophiobolin A

    3-Anhydro-6-epi-ophiobolin A

    A sesterterpenoid fungal metabolite
  10. GC40556 Ac-LETD-AFC

    NAcetylLeuGluThrAsp7amino4Trifluoromethylcoumarin, Caspase8 Substrate (Fluorogenic)

    A caspase-8 fluorogenic substrate
  11. GC40483 Patulin

    棒曲霉素; Terinin

    A mycotoxin

  12. GC40334 Myristoleic Acid methyl ester

    肉豆蔻脑酸甲酯

    Methyl ester of the cytotoxin myristoleic acid
  13. GC19541 (rac)-Antineoplaston A10

    3-苯基乙酰氨基-2,6-哌啶二酮

    (rac)-Antineoplaston A10 是 Antineoplaston A10 的外消旋体。 Antineoplaston A10 是一种潜在的 Ras 抑制剂,可用于治疗神经胶质瘤、淋巴瘤、星形细胞瘤和乳腺癌。
  14. GC19537 β-Elemene

    β-榄香烯; (-)-β-Elemene; Levo-β-elemene

    β-Elemene是从天然植物温郁金(Curcuma aromatica)中提取的一种单萜类化合物,具有抗肿瘤活性。
  15. GC19533 Infliximab

    英夫利昔单抗,Avakine; CT-P13

    英夫利昔单抗是一种嵌合单克隆 IgG1 抗体,可特异性结合 TNF-α。

  16. GC19531 Pembrolizumab

    派姆单抗,帕博利珠单抗,Lambrolizumab; MK-3475

    Pembrolizumab 是一种抗程序性死亡 1 单克隆抗体,已在晚期实体癌患者中证明具有临床显着的抗肿瘤活性和可接受的安全性,并已被美国 FDA 批准用于治疗晚期黑色素瘤、NSCLC、头颅和脑肿瘤。
  17. GC34929 PD-1-IN-17 TFA An inhibitor of PD-1 signaling
  18. GC34928 PD-1-IN-17 An inhibitor of PD-1 signaling
  19. GC34862 WYC-209

    4,5-二(羟甲基)-2-苯基-1H-咪唑

    WYC-209是一种合成类视黄醇,能抑制恶性小鼠黑色素瘤肿瘤再生细胞(TRC)的增殖,IC50值为0.19μM。WYC-209主要细胞靶点是维甲酸受体(RARs)。
  20. GC34831 Tauroursodeoxycholate dihydrate

    牛磺熊去氧胆酸二水合物; Tauroursodeoxycholic acid dihydrate; TUDCA dihydrate; UR 906 dihydrate

    Tauroursodeoxycholatedihydrate(TUDCAdihydrate;UR906dihydrate;Taurolitedihydrate)是一种内质网应激抑制剂。Tauroursodeoxycholate显著降低凋亡分子如caspase-3和caspase-12表达。Tauroursodeoxycholate也抑制ERK。
  21. GC34642 KI696 isomer KI696isomer是KI696的低活性异构体。KI696是一种高亲和力探针,可破坏Keap1/NRF2相互作用。
  22. GC34634 JG-98

    3-苄基-2-((Z)-((E)-5-(6-氯-3-甲基苯并[D]噻唑-2(3H)-亚基)-3-乙基-4-氧代噻唑啉-2-亚基)甲基)噻唑-3-鎓氯化物

    JG-98 is an allosteric inhibitor of Hsp70 that binds tightly to a deep pocket that is conserved in members of the Hsp70 family. JG-98 induces classical apoptosis features, including morphological changes consistent with programmed cell death and positive annexin staining. JG-98 exhibits anticancer activity.
  23. GC34606 GSK-843

    GSK'843

    GSK-843是一种受体相互作用蛋白激酶3(RIP3orRIPK3)抑制剂,高亲和力结合RIP3激酶结构域,IC50值为8.6nM,并抑制激酶活性,IC50值为6.5nM。
  24. GC34605 GSK840

    GSK'840

    GSK840(GSK’840)是一种受体相互作用蛋白激酶3(RIP3orRIPK3)抑制剂,高亲和力结合RIP3激酶结构域,IC50值为0.9nM,并抑制激酶活性,IC50值为0.3nM。

  25. GC34579 Etanercept

    依那西普

    Etanercept是一种竞争性肿瘤坏死因子(TNF)抑制剂,抑制TNF-α和TNF-β与细胞表面受体的结合。
  26. GC34543 cRIPGBM cRIPGBM是RIPGBM的促凋亡衍生物,是通过与受体相互作用蛋白激酶2(RIPK2)结合,诱导GBM肿瘤干细胞凋亡的选择性诱导剂,对GBM-1细胞的EC50值为68nM。
  27. GC34513 C25-140 C25-140 is a small-molecule inhibitor of TRAF6-Ubc13 interaction. C25-140 directly binds to TRAF6, thereby blocking the interaction of TRAF6 with Ubc13, and as a consequence lowers TRAF6 activity. C25-140 impedes NF-κB activation in various immune and inflammatory signaling pathways also in primary human and murine cells.
  28. GC34511 BTR-1 BTR-1 induces cytotoxicity in a time- and concentration-dependent manner on leukemia cell line CEM. BTR-1 affects DNA replication by inducing a block at S phase and leads to activation of apoptosis to induce cell death.
  29. GC19522 Sodium oleate

    油酸钠,cis-9-Octadecenoic acid sodium salt, Oleic acid sodium salt

    A monounsaturated fatty acid
  30. GC10150 Necrosulfonamide

    N-[4-[[(3-甲氧基吡嗪基)氨基]磺酰基]苯基]-3-(5-硝基-2-噻吩基)-2-丙烯酰胺

    Necrosulfonamide(NSA)是MLKL(混合系激酶域样蛋白)的一种特异性抑制剂。
  31. GC19503 GSK547

    GSK'547

    GSK547 (GSK'547) 是受体相互作用的丝氨酸/苏氨酸蛋白激酶 1 (RIPK1) 的高选择性和强效抑制剂,可抑制巨噬细胞介导的胰腺癌适应性免疫耐受。
  32. GC40226 Curcumin-d6

    (1E,4Z,6E)-5-羟基-1,7-二[4-羟基-3-(甲氧基-D3)苯基]-1,4,6-庚三烯-3-酮,Diferuloylmethane-d6; Natural Yellow 3-d6; Turmeric yellow-d6

    An internal standard for the quantification of curcumin
  33. GC40222 Lapatinib-d4 (tosylate) An internal standard for the quantification of lapatinib
  34. GC40218 (-)-Epigallocatechin Gallate-d3/d4

    EGCG-d3/d4

    An internal standard for the quantification of (–)-epigallocatechin gallate
  35. GC40215 Viridicatumtoxin

    NSC 159628

    A mycotoxin with diverse biological activities
  36. GC40214 Anhydroophiobolin A

    Anhydrocochliobolin A, 3-Anhydroophiobolin A

    A fungal metabolite
  37. GC40192 DMPAC-Chol

    Chol-T

    A cationic cholesterol derivative
  38. GC40164 Ac-IETD-CHO (trifluoroacetate salt)

    Caspase-8 Inhibitor

    A caspase-8 inhibitor
  39. GC40162 Ac-VEID-pNA (trifluoroacetate salt)

    Ac-Val-Glu-Ile-Asp-pNA, Ac-Val-Glu-Ile-Asp-p-nitroanilide, Caspase-6 Chromogenic Substrate

    A colorimetric caspase-6 substrate
  40. GC40155 Biotin-DEVD-CHO (trifluoroacetate salt)

    Biotin-Asp-Glu-Val-Asp-CHO

    A biotinylated caspase-3 and -7 inhibitor
  41. GC40154 Ac-ESMD-CHO (trifluoroacetate salt)

    Ac-Glu-Ser-Met-Asp-CHO

    An inhibitor of caspase-3 maturation
  42. GC40153 Z-YVAD-AFC (trifluoroacetate salt)

    Z-Tyr-Val-Ala-Asp-AFC, Z-Tyr-Val-Ala-Asp-7-amino-4-trifluoromethylcoumarin, Z-YVAD-7-amino-4-trifluoromethylcoumarin

    A fluorogenic substrate for caspase-1
  43. GC40152 Ac-IEPD-pNA (trifluoroacetate salt)

    Ac-Ile-Glu-Pro-Asp-p-nitroanilide, Caspase-8 Chromogenic Substrate, Granzyme B Substrate VIII

    A colorimetric granzyme B and caspase-8 substrate
  44. GC40151 Z-VAD-AMC (acetate)

    Z-Val-Ala-Asp-AMC, Z-Val-Ala-Asp-7-amino-4-methylcoumarin

    A caspase-1 fluorogenic substrate
  45. GC40150 Z-VEID-AFC (trifluoroacetate salt)

    Z-Val-Glu-Ile-Asp-AFC, Z-Val-Glu-Ile-Asp-7-amino-4-trifluormethylcoumarin

    A fluorogenic substrate for caspase-6
  46. GC40149 Boc-AEVD-CHO (trifluoroacetate salt)

    Boc-Ala-Glu-Val-Asp-CHO

    An inhibitor of caspase-8
  47. GC40141 C18 Phytoceramide-d3 (t18:0/18:0-d3)

    Cer(t18:0/18:0) - d3, Ceramide (t18:0/18:0)- d3, N-Octadecanoyl Phytosphingosine- d3, C18:0 Phytoceramide- d3, N-Stearoyl Phytosphingosine- d3

    An internal standard for the quantification of C18 phytoceramide
  48. GC40125 Z-VA-DL-D(OMe)-FMK (trifluoroacetate salt)

    Caspase-1 Inhibitor V, Z-VAD-FMK, Z-VAD(OMe)-FMK, Z-Val-Ala-DL-Asp(OMe)-Fluoromethyl Ketone

    A pan-caspase inhibitor
  49. GC40124 Ac-WEAD-AMC (trifluoroacetate salt)

    Ac-Trp-Glu-Ala-Asp-AMC

    A caspase-1 and caspase-4 fluorogenic substrate
  50. GC40123 Ac-AAVALLPAVLLALLAP-VAD-CHO (trifluoroacetate salt)

    Caspase Inhibitor II, Ac-AAVALLPAVLLALLAP-VAD-aldehyde, Ac-AAVALLPAVLLALLAPVAD-CHO

    A non-selective caspase inhibitor
  51. GC40122 Ac-AAVALLPAVLLALLAP-DEVD-CHO (trifluoroacetate salt)

    Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Asp-Glu-Val-Asp-CHO, Ac-AAVALLPAVLLALLAP-DEVD-aldehyde, Ac-AAVALLPAVLLALLAPDEVD-CHO, Caspase-3 Inhibitor I, DEVD-CHO-CPP 32

    A caspase-3 inhibitor

Items 1651 to 1700 of 2733 total

per page

Set Descending Direction